Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypertension

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 88 articles: HTML format

Single Articles

May 2024
1. OU YH, Colpani JT, Cheong CS, Loke W, et al
   Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients With Obstructive Sleep Apnea.
   J Am Coll Cardiol. 2024;83:1760-1772.
   PubMed     Abstract available
   
   
   April 2024
2. BOULESTREAU R, Spiewak M, Januszewicz A, Kreutz R, et al
   Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
   J Am Coll Cardiol. 2024;83:1688-1701.
   PubMed     Abstract available
   
   
   
3. BEKHUIS Y, Verwerft J, Claessen G
   Exercise Echocardiography for mPAP/CO Slope Estimation: A New Standard for Routine Clinical Care?
   J Am Coll Cardiol. 2024;83:e141-e142.
   PubMed    
   
   
   
4. WRIGHT CB, Egle M
   Rethinking Blood Pressure Treatment and Dementia Risk in Older Adults: Is Adherence the Holy Grail?
   J Am Coll Cardiol. 2024;83:1204-1206.
   PubMed    
   
   
   
5. REA F, Corrao G, Mancia G
   Risk of Dementia During Antihypertensive Drug Therapy in the Elderly.
   J Am Coll Cardiol. 2024;83:1194-1203.
   PubMed     Abstract available
   
   
   March 2024
6. LOWERY MM, Hill NS, Wang L, Mehra R, et al
   Reply: Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
   J Am Coll Cardiol. 2024;83:e109.
   PubMed    
   
   
   
7. HUANG Z, Duan A, Luo Q, Liu Z, et al
   Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
   J Am Coll Cardiol. 2024;83:e107.
   PubMed    
   
   
   February 2024
8. OLDE ENGBERINK RHG
   Salt Intake: Reduce or Substitute?
   J Am Coll Cardiol. 2024;83:723-725.
   PubMed    
   
   
   
9. ZHANG X, Yuan Y, Li C, Feng X, et al
   Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults.
   J Am Coll Cardiol. 2024;83:711-722.
   PubMed     Abstract available
   
   
   
10. HALL ME, Mace HP, Hall JE
    Bariatric Surgery for Obesity Hypertension: A Gateway for Durable Blood Pressure Control.
    J Am Coll Cardiol. 2024;83:649-651.
    PubMed    
    
    
    
11. SCHIAVON CA, Cavalcanti AB, Oliveira JD, Machado RHV, et al
    Randomized Trial of Effect of Bariatric Surgery on Blood Pressure After 5 Years.
    J Am Coll Cardiol. 2024;83:637-648.
    PubMed     Abstract available
    
    
    January 2024
12. WESSELS JN, Bogaard HJ
    Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension: Possible Benefits for Selected Patients.
    J Am Coll Cardiol. 2024;83:485-487.
    PubMed    
    
    
    
13. GRUNIG E, Jansa P, Fan F, Hauser JA, et al
    Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2024;83:473-484.
    PubMed     Abstract available
    
    
    November 2023
14. JAVAHERI S, Somers VK
    Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?
    J Am Coll Cardiol. 2023;82:2006-2008.
    PubMed    
    
    
    
15. LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al
    Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2023;82:1989-2005.
    PubMed     Abstract available
    
    
    
16. MATHIAS W JR, Le Bihan DCS, Hajjar LA
    Stress Echocardiography: Another Hilltop, and It Is Better Than Ever.
    J Am Coll Cardiol. 2023;82:1986-1988.
    PubMed    
    
    
    
17. GARGANI L, Pugliese NR, De Biase N, Mazzola M, et al
    Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation.
    J Am Coll Cardiol. 2023;82:1973-1985.
    PubMed     Abstract available
    
    
    
18. VINAYAK M, Olin JW, Stone GW
    The Ongoing Odyssey of Renal Denervation.
    J Am Coll Cardiol. 2023;82:1824-1827.
    PubMed    
    
    
    
19. KANDZARI DE, Townsend RR, Kario K, Mahfoud F, et al
    Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
    J Am Coll Cardiol. 2023;82:1809-1823.
    PubMed     Abstract available
    
    
    September 2023
20. MORAN AE, Gupta R
    Implementation of Global Hearts Hypertension Control Programs in 32 Low- and Middle-Income Countries: JACC International.
    J Am Coll Cardiol. 2023 Sep 19:S0735-1097(23)06633.
    PubMed     Abstract available
    
    
    August 2023
21. COSTANZO MR, Marwick TH
    Right Atrium as Barometer of Right Ventricular Stiffness and Treatment Responsiveness in Precapillary Pulmonary Hypertension.
    J Am Coll Cardiol. 2023;82:718-720.
    PubMed    
    
    
    
22. WESSELS JN, van Wezenbeek J, de Rover J, Smal R, et al
    Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis.
    J Am Coll Cardiol. 2023;82:704-717.
    PubMed     Abstract available
    
    
    April 2023
23. DAUGHERTY A, Lu HS, Bakris GL
    Angiotensinogen in Sex and Hypertension: New Insights From the Multi-Ethnic Study of Atherosclerosis (MESA).
    J Am Coll Cardiol. 2023;81:1260-1262.
    PubMed    
    
    
    
24. TRAINOR PJ, Brambatti M, Carlisle SM, Mullick AE, et al
    Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA).
    J Am Coll Cardiol. 2023;81:1248-1259.
    PubMed     Abstract available
    
    
    March 2023
25. VENTURA HO, Elagizi A, Lavie CJ
    Optimal Prevention of Cardiovascular Diseases: The Earlier the Better.
    J Am Coll Cardiol. 2023;81:1162-1164.
    PubMed    
    
    
    February 2023
26. ASCHER SB, de Lemos JA, Lee M, Berry JD, et al
    Reply: Malignant Hypertensive Cardiomyopathy: Definition Matters.
    J Am Coll Cardiol. 2023;81:e59.
    PubMed    
    
    
    
27. BOULESTREAU R, Gosse P, Doublet J, Cremer A, et al
    Malignant Hypertensive Cardiomyopathy: Definition Matters.
    J Am Coll Cardiol. 2023;81:e57-e58.
    PubMed    
    
    
    
28. FUSTER V
    Editor-in-Chief's Top Picks From 2022.
    J Am Coll Cardiol. 2023;81:780-841.
    PubMed     Abstract available
    
    
    
29. FORFIA PR
    Association of Left Ventricular Filling Pressure With Chronic Thromboembolic Pulmonary Hypertension: A Matter of Perspective.
    J Am Coll Cardiol. 2023;81:665-667.
    PubMed    
    
    
    
30. GERGES C, Pistritto AM, Gerges M, Friewald R, et al
    Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.
    J Am Coll Cardiol. 2023;81:653-664.
    PubMed     Abstract available
    
    
    
31. AL GHORANI H, Kulenthiran S, Recktenwald MJM, Lauder L, et al
    10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension.
    J Am Coll Cardiol. 2023;81:517-519.
    PubMed    
    
    
    December 2022
32. MA H, Wang X, Li X, Heianza Y, et al
    Adding Salt to Foods and Risk of Cardiovascular Disease.
    J Am Coll Cardiol. 2022;80:2157-2167.
    PubMed     Abstract available
    
    
    November 2022
33. BHATT DL
    The Rise and Fall and Rise of Renal Denervation.
    J Am Coll Cardiol. 2022;80:1881-1883.
    PubMed    
    
    
    
34. MAHFOUD F, Mancia G, Schmieder RE, Ruilope L, et al
    Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.
    J Am Coll Cardiol. 2022;80:1871-1880.
    PubMed     Abstract available
    
    
    October 2022
35. GENEREUX P
    Pulmonary Hypertension and Aortic Stenosis: A Piece of the Puzzle.
    J Am Coll Cardiol. 2022;80:1614-1616.
    PubMed    
    
    
    
36. MIYAMOTO J, Ohno Y, Kamioka N, Ikari Y, et al
    Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2022;80:1601-1613.
    PubMed     Abstract available
    
    
    
37. DEFILIPPI CR, Seliger S
    Malignant Left Ventricular Hypertrophy and Epidemiology 101.
    J Am Coll Cardiol. 2022;80:1526-1528.
    PubMed    
    
    
    
38. ASCHER SB, de Lemos JA, Lee M, Wu E, et al
    Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2022;80:1516-1525.
    PubMed     Abstract available
    
    
    
39. JANUSZEWICZ A, Mulatero P, Dobrowolski P, Monticone S, et al
    Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:1480-1497.
    PubMed     Abstract available
    
    
    
40. BRILLER JE
    Echocardiographic Screening in Hypertensive Pregnancy Disorders: Probing the Window of Opportunity.
    J Am Coll Cardiol. 2022;80:1477-1479.
    PubMed    
    
    
    
41. GIORGIONE V, Khalil A, O'Driscoll J, Thilaganathan B, et al
    Peripartum Screening for Postpartum Hypertension in Women With Hypertensive Disorders of Pregnancy.
    J Am Coll Cardiol. 2022;80:1465-1476.
    PubMed     Abstract available
    
    
    September 2022
42. DONADILLE B, Valent A, Amemiya K, Rive le Gouard N, et al
    Aortic Tissue Analysis in Turner Syndrome.
    J Am Coll Cardiol. 2022;80:1284-1285.
    PubMed    
    
    
    
43. WANG N, Harris K, Hamet P, Harrap S, et al
    Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes.
    J Am Coll Cardiol. 2022;80:1147-1155.
    PubMed     Abstract available
    
    
    August 2022
44. POKHAREL Y, Karmacharya BM, Neupane D
    Hypertension-A Silent Killer Without Global Bounds: What Next?
    J Am Coll Cardiol. 2022;80:818-820.
    PubMed    
    
    
    
45. KIRSCHBAUM TK, Sudharsanan N, Manne-Goehler J, De Neve JW, et al
    The Association of Socioeconomic Status With Hypertension in 76 Low- and Middle-Income Countries.
    J Am Coll Cardiol. 2022;80:804-817.
    PubMed     Abstract available
    
    
    
46. WILKINS MR
    Pulmonary Hypertension: Dissecting a Complex Phenotype.
    J Am Coll Cardiol. 2022;80:719-721.
    PubMed    
    
    
    
47. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
    Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
    J Am Coll Cardiol. 2022;80:565-578.
    PubMed     Abstract available
    
    
    
48. WHELTON PK, Carey RM, Mancia G, Kreutz R, et al
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.
    J Am Coll Cardiol. 2022 Aug 4. pii: S0735-1097(22)05593.
    PubMed     Abstract available
    
    
    July 2022
49. KOTTKE TE, Gupta AK, Thomas RJ
    Failing Cardiovascular Health: A Population Code Blue.
    J Am Coll Cardiol. 2022;80:152-154.
    PubMed    
    
    
    June 2022
50. CHOU JC
    Hypertensive Disorders of Pregnancy and Cardiovascular Risk: We Are Missing the Opportunity of a Lifetime.
    J Am Coll Cardiol. 2022;79:2412-2414.
    PubMed    
    
    
    
51. LEVINE LD, Ky B, Chirinos JA, Koshinksi J, et al
    Prospective Evaluation of Cardiovascular Risk 10 Years After a Hypertensive Disorder of Pregnancy.
    J Am Coll Cardiol. 2022;79:2401-2411.
    PubMed     Abstract available
    
    
    May 2022
52. SHARMA G, Ipek EG, Grandi SM
    The Impact of Hypertensive Disorders of Pregnancy on Cardiovascular Outcomes: Flying Under the Radar.
    J Am Coll Cardiol. 2022;79:1914-1916.
    PubMed    
    
    
    
53. STUART JJ, Tanz LJ, Rimm EB, Spiegelman D, et al
    Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy.
    J Am Coll Cardiol. 2022;79:1901-1913.
    PubMed     Abstract available
    
    
    
54. LEE HH, Lee H, Townsend RR, Kim DW, et al
    Cardiovascular Implications of the 2021 KDIGO Blood Pressure Guideline for Adults With Chronic Kidney Disease.
    J Am Coll Cardiol. 2022;79:1675-1686.
    PubMed     Abstract available
    
    
    April 2022
55. REGENSTEINER JG, Reusch JEB
    Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and Diabetes: JACC Focus Seminar 4/7.
    J Am Coll Cardiol. 2022;79:1492-1505.
    PubMed     Abstract available
    
    
    January 2022
56. VASAN RS, Enserro DM, Beiser AS, Xanthakis V, et al
    Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
    J Am Coll Cardiol. 2022;79:250-263.
    PubMed     Abstract available
    
    
    
57. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
    Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:166-179.
    PubMed     Abstract available
    
    
    December 2021
58. OGUNNIYI MO, Commodore-Mensah Y, Ferdinand KC
    Race, Ethnicity, Hypertension, and Heart Disease: JACC Focus Seminar 1/9.
    J Am Coll Cardiol. 2021;78:2460-2470.
    PubMed     Abstract available
    
    
    
59. LEWANDOWSKI AJ
    Reply: Does Gestational Hypertension Contribute to Myocardial Fibrosis and Diastolic Dysfunction in Adult Offspring?
    J Am Coll Cardiol. 2021;78:e299.
    PubMed    
    
    
    
60. ARMSTRONG DWJ, Tse MY, Pang SC
    Does Gestational Hypertension Contribute to Myocardial Fibrosis and Diastolic Dysfunction in Adult Offspring?
    J Am Coll Cardiol. 2021;78:e297.
    PubMed    
    
    
    October 2021
61. MESSERLI FH, Shalaeva EV, Rexhaj E
    Optimal BP Targets to Prevent Stroke and MI: Is There a Lesser of 2 Evils?
    J Am Coll Cardiol. 2021;78:1679-1681.
    PubMed    
    
    
    
62. MCCULLOUGH SA, Goff DC Jr, Okin PM
    On-Treatment Hypertension Control in a Real-World Cohort: Lower Blood Pressure Remains Better.
    J Am Coll Cardiol. 2021;78:1496-1498.
    PubMed    
    
    
    
63. LEE HH, Lee H, Cho SMJ, Kim DW, et al
    On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2021;78:1485-1495.
    PubMed     Abstract available
    
    
    
64. LEOPOLD JA
    Initial Triple Pharmacotherapy in Pulmonary Arterial Hypertension: Is More Necessarily Better?
    J Am Coll Cardiol. 2021;78:1404-1406.
    PubMed    
    
    
    
65. CHIN KM, Sitbon O, Doelberg M, Feldman J, et al
    Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2021;78:1393-1403.
    PubMed     Abstract available
    
    
    September 2021
66. EGAN BM
    Baseline Heart Rate Predicts the Blood Pressure Response to Renal Denervation in Untreated Hypertension.
    J Am Coll Cardiol. 2021;78:1039-1041.
    PubMed    
    
    
    
67. BOHM M, Tsioufis K, Kandzari DE, Kario K, et al
    Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.
    J Am Coll Cardiol. 2021;78:1028-1038.
    PubMed     Abstract available
    
    
    August 2021
68. GUTIERREZ J, Khasiyev F, Liu M, DeRosa JT, et al
    Determinants and Outcomes of Asymptomatic Intracranial Atherosclerotic Stenosis.
    J Am Coll Cardiol. 2021;78:562-571.
    PubMed     Abstract available
    
    
    
69. SCHRANZ D
    Reverse Potts Shunt for Pulmonary Hypertension: Back to a "Fetal" Circulation in Part?
    J Am Coll Cardiol. 2021;78:478-480.
    PubMed    
    
    
    
70. GRADY RM, Canter MW, Wan F, Shmalts AA, et al
    Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.
    J Am Coll Cardiol. 2021;78:468-477.
    PubMed     Abstract available
    
    
    July 2021
71. SCIATTI E, Orabona R
    Cardiovascular Prevention After Hypertensive Disorders of Pregnancy: Do Not Forget Fetal Growth Restriction!
    J Am Coll Cardiol. 2021;78:91.
    PubMed    
    
    
    
72. COUNTOURIS ME, Villanueva FS, Catov JM
    Reply: Cardiovascular Prevention After Hypertensive Disorders of Pregnancy: Do Not Forget Fetal Growth Restriction!
    J Am Coll Cardiol. 2021;78:91-92.
    PubMed    
    
    
    June 2021
73. OETGEN WJ, Wright JS
    Controlling Hypertension: Our Cardiology Practices Can Do a Better Job.
    J Am Coll Cardiol. 2021;77:2973-2977.
    PubMed    
    
    
    
74. MAHFOUD F, Townsend RR, Kandzari DE, Kario K, et al
    Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.
    J Am Coll Cardiol. 2021;77:2909-2919.
    PubMed     Abstract available
    
    
    
75. RAO VU, Reeves DJ, Chugh AR, O'Quinn R, et al
    Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2693-2716.
    PubMed     Abstract available
    
    
    
76. JURASCHEK SP, Kovell LC, Appel LJ, Miller ER 3rd, et al
    Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation: The DASH-Sodium Trial.
    J Am Coll Cardiol. 2021;77:2625-2634.
    PubMed     Abstract available
    
    
    May 2021
77. AL-MASHHADI RH, Bentzon JF
    Reply: Hypertension-Accelerated Atherogenesis: Barely Scratching the Surface.
    J Am Coll Cardiol. 2021;77:2620-2621.
    PubMed    
    
    
    
78. ASLANGER EK
    The Real Offending Factor in Hypertension: Pressure or Flow?
    J Am Coll Cardiol. 2021;77:2619.
    PubMed    
    
    
    
79. WANG X, Ge J
    Hypertension Aggravates Atherosclerosis: A Matter of Pressure Remodeling of Myofibroblasts or LDL Accumulation?
    J Am Coll Cardiol. 2021;77:2619-2620.
    PubMed    
    
    
    
80. JANUZZI JL JR, Mohebi R
    Obesity-Mediated Disruption of Natriuretic Peptide-Blood Pressure Rhythms.
    J Am Coll Cardiol. 2021;77:2304-2306.
    PubMed    
    
    
    April 2021
81. VEDANTHAN R, Kamano JH, Chrysanthopoulou SA, Mugo R, et al
    Group Medical Visit and Microfinance Intervention for Patients With Diabetes or Hypertension in Kenya.
    J Am Coll Cardiol. 2021;77:2007-2018.
    PubMed     Abstract available
    
    
    
82. JAFAR TH, Kyobutungi C
    A Good Start to Lowering BP and CVD Risk in Sub-Saharan Africa.
    J Am Coll Cardiol. 2021;77:2019-2021.
    PubMed    
    
    
    
83. DIAMOND JA, Schussheim AE, Phillips RA
    Another Nudge to Overcome the Treatment-Risk Paradox in Blood Pressure Management.
    J Am Coll Cardiol. 2021;77:1991-1993.
    PubMed    
    
    
    
84. BRESS AP, Greene T, Derington CG, Shen J, et al
    Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.
    J Am Coll Cardiol. 2021;77:1977-1990.
    PubMed     Abstract available
    
    
    
85. MESSERLI FH, Bavishi C, Bangalore S
    Renal Denervation in Hypertension: Barking Up the Wrong Tree?
    J Am Coll Cardiol. 2021 Apr 22. pii: S0735-1097(21)04816.
    PubMed    
    
    
    
86. SCHWARTZ JE, Muntner P, Shimbo D
    Reply: Reliable Diagnosis of Hypertension: What Is the Best Approach?
    J Am Coll Cardiol. 2021;77:1956-1957.
    PubMed    
    
    
    
87. TADIC M, Cuspidi C
    Reliable Diagnosis of Hypertension: What Is the Best Approach?
    J Am Coll Cardiol. 2021;77:1955-1956.
    PubMed    
    
    
    March 2021
88. BAKRIS G, Sternlicht H
    Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control.
    J Am Coll Cardiol. 2021;77:1300-1301.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.